首页> 美国卫生研究院文献>PLoS Clinical Trials >Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis

【2h】

Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis

机译：三联疗法与双重抗血小板疗法对房颤患者行冠状动脉支架置入术的疗效和安全性的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundThe optimal antithrombotic therapy for atrial fibrillation (AF) patients undergoing coronary stenting is unknown. The present meta-analysis sought to investigate the efficacy and safety of triple therapy (TT; warfarin, clopidogrel and aspirin) vs dual antiplatelet therapy (DAPT; clopidogrel plus aspirin) in those patients.

机译：背景技术尚不清楚用于进行冠状动脉支架置入术的房颤（AF）患者的最佳抗血栓治疗方法。本荟萃分析旨在研究三联疗法（TT；华法林，氯吡格雷和阿司匹林）与双重抗血小板疗法（DAPT；氯吡格雷加阿司匹林）在这些患者中的疗效和安全性。

著录项

期刊名称 PLoS Clinical Trials
作者
Liyao Liu; Jietao Huang; Xiaogang Zhang; Xiaoman Tang;
展开▼
作者单位

展开▼
年(卷),期 2012(13),6
年度 2012
页码 e0199232
总页数 17
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention [J] . Cavallari Ilaria, Patti Giuseppe The American Journal of Cardiology . 2018,第6期

机译：荟萃分析比较了双重抗血栓检查的安全性和功效在经皮冠状动脉介入的心房颤动患者中
2. Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention [J] . Cavallari Ilaria, Patti Giuseppe The American Journal of Cardiology . 2018,第6期

机译：荟萃分析比较了双重抗血栓检查的安全性和功效在经皮冠状动脉介入的心房颤动患者中
3. Design and Rationale of the RE‐DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting [J] . Cannon Christopher P., Gropper Savion, Bhatt Deepak L., Clinical cardiology. . 2016,第10期

机译：重新双PCI试验的设计与理由：一种预期，随机，第3B阶段研究比较双抗血栓形成治疗与Dabigatran的安全性和功效与达比林素三重治疗，在非衰弱性心房颤动的患者中经过经过经过经皮冠状动脉干预
4. ICD Patients: What Is the Efficacy of Early Actuation of Atrial ATP Therapies in Atrial Fibrillation Termination? [C] . M. SANTINI, G. ALTAMURA, S. FAVALE, International Workshop on Cardiac Arrhythmias . 2002

机译：ICD患者：早期发生心房颤动终止的心房ATP疗法的疗效是什么？
5. Optimal Post-Procedural Therapy for Patients Ineligble for Treatment with Oral Anticoagulatiion Who Undergo Left Atrial Appendage Occlusion with the Watchman Device for Non-Valvular Atrial Fibrillation [D] . Whitehead, Kristen Marie. 2020

机译：用口腔抗凝血治疗患者患者的最佳过程治疗患者患有左心房阑尾闭塞与鹰刀用于非瓣膜心房颤动
6. Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group open-label blinded-endpoint superiority multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting [O] . Lisa Riesinger, Claudia Strobl, David M. Leistner, 2021

机译：Apixaban与苯procoumon：口服抗凝加抗血小板治疗急性冠状动脉综合征和心房颤动的患者（方法-ACS-AF）：理论和设计前瞻性随机平行开放标签盲 - 终点优势多中心试验对心房颤动患者的三重治疗与双重治疗和急性冠状动脉综合征接受冠状动脉抵抗
7. Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis [O] . Liyao Liu, Jietao Huang, Xiaogang Zhang, 2018

机译：三重治疗与双抗血小板治疗患者心房颤动患者的疗效和安全性：META分析

Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅